NORTH AMERICAN COMPANY FOR LIFE AND HEALTH INSURANCE Insurance Complaints in 2025
Year-in-review analysis of 2 insurance complaints filed against NORTH AMERICAN COMPANY FOR LIFE AND HEALTH INSURANCE during 2025, based on public NAIC and state DOI data.
Key Statistics
- Complaints in 2025: 2
- Total Complaints (All Time): 61
- 2025 Share: 3.3%
- Coverage Types: 1
- States Affected: 1
- AI Risk Score: 72/100
2025 Complaint Analysis for NORTH AMERICAN COMPANY FOR LIFE AND HEALTH INSURANCE
In 2025, NORTH AMERICAN COMPANY FOR LIFE AND HEALTH INSURANCE received 2 insurance complaints from consumers across 1 state and 1 coverage type. This represents 3.3% of NORTH AMERICAN COMPANY FOR LIFE AND HEALTH INSURANCE's all-time complaint volume.
The leading category was health with 2 complaints.
Geographically, Texas led with 2 complaints.
2025 Complaints by Category
| Coverage Type | Complaints | % |
|---|---|---|
| health | 2 | 100.0% |
2025 Complaints by State
| State | Complaints |
|---|---|
| Texas | 2 |
NORTH AMERICAN COMPANY FOR LIFE AND HEALTH INSURANCE Complaints from 2025
- health Complaint #TX-442592-5b840d8d — Texas (2025-12-16)
- health Complaint #TX-414705-9634d391 — Texas (2025-01-29)
Frequently Asked Questions
How many complaints did NORTH AMERICAN COMPANY FOR LIFE AND HEALTH INSURANCE receive in 2025?
NORTH AMERICAN COMPANY FOR LIFE AND HEALTH INSURANCE received 2 insurance complaints in 2025, according to NAIC and state DOI data.
What types of complaints were filed against NORTH AMERICAN COMPANY FOR LIFE AND HEALTH INSURANCE in 2025?
The most common types: health (2).
Which states had the most complaints against NORTH AMERICAN COMPANY FOR LIFE AND HEALTH INSURANCE in 2025?
Top states: Texas (2).
Is NORTH AMERICAN COMPANY FOR LIFE AND HEALTH INSURANCE's complaint volume increasing or decreasing?
NORTH AMERICAN COMPANY FOR LIFE AND HEALTH INSURANCE's complaint history: 2026 (5), 2025 (2), 2024 (4), 2023 (5), 2022 (3), 2021 (7), 2020 (3), 2019 (3), 2018 (4), 2017 (5), 2016 (3), 2015 (2), 2014 (8), 2013 (3), 2012 (4).